Sandbox Reserved 818: Difference between revisions
Paul Giroud (talk | contribs) No edit summary |
Paul Giroud (talk | contribs) |
||
(31 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
[[Image:Pertussis_toxin_complex.png|thumb|left| | <applet load="1prt" size="350" color="white" frame="true" align="right" caption="Pertussis Toxin produced and secreted by ''Bordetella pertussis''" scene=56/568016/Ptx_full/2 /> | ||
'''Pertussis Toxin (PTX)''' is a toxin produced and secreted by the bacteria ''Bordetella pertussis'', also known as the [http://en.wikipedia.org/wiki/Whooping_cough whooping cough] agent. | |||
[[Image:Pertussis_toxin_complex.png|thumb|left|300px|Cartoon representation of the molecular structure of pertussis toxin.]] | |||
'''Pertussis Toxin (PTX)''' is a toxin produced and secreted by the bacteria [http://fr.wikipedia.org/wiki/Bordetella_pertussis ''Bordetella pertussis''], also known as the [http://en.wikipedia.org/wiki/Whooping_cough whooping cough] agent. | |||
It is a complex soluble bacterial [[:wiktionary:holotoxin|Holotoxin]], composed of 5 subuntits (named S1 to S5 according to their decreasing molecular weights), arranged in an A-B structure. The A part contains the enzymatically active <scene name='56/568016/Ptx_s1/1'>S1</scene> subunit, which catalyzes ADP-ribosylation of α subunit of [http://en.wikipedia.org/wiki/G_protein trimeric G proteins], thereby disturbing major metabolic functions of the target cells, leading to a variety of biological activities. | It is a complex soluble bacterial [[:wiktionary:holotoxin|Holotoxin]], composed of 5 subuntits (named S1 to S5 according to their decreasing molecular weights), arranged in an A-B structure. The A part contains the enzymatically active <scene name='56/568016/Ptx_s1/1'>S1</scene> subunit, which catalyzes ADP-ribosylation of α subunit of [http://en.wikipedia.org/wiki/G_protein trimeric G proteins], thereby disturbing major metabolic functions of the target cells, leading to a variety of biological activities. | ||
The B oligomer is composed by <scene name='56/568016/Ptx_s2/2'>1S2</scene>:<scene name='56/568016/Ptx_s3/1'>1S3</scene>:<scene name='56/568016/Ptx_s4/1'>2S4</scene>:<scene name='56/568016/Ptx_s5/1'>1S5</scene> and is responsible for binding of the toxin to target cell receptors and for intracellular traficking. | The <scene name='56/568016/Ptx_b/1'>B oligomer</scene> is composed by <scene name='56/568016/Ptx_s2/2'>1S2</scene>:<scene name='56/568016/Ptx_s3/1'>1S3</scene>:<scene name='56/568016/Ptx_s4/1'>2S4</scene>:<scene name='56/568016/Ptx_s5/1'>1S5</scene> and is responsible for binding of the toxin to target cell receptors and for intracellular traficking. | ||
This toxin is a major virulence factor of ''B. pertussis'' and is a component of vaccines against [http://en.wikipedia.org/wiki/Whooping_cough whooping cough]. | This toxin is a major virulence factor of ''B. pertussis'' and is a component of vaccines against [http://en.wikipedia.org/wiki/Whooping_cough whooping cough]. | ||
==Binding of pertussis toxin to its cellular targets== | ==Binding of pertussis toxin to its cellular targets== | ||
After being secreted by the ''Ptl machinery'' | After being secreted by the ''Ptl machinery'' (a member of the [http://en.wikipedia.org/wiki/Secretion#Type_IV_secretion_system_.28T4SS_or_TFSS.29 type IV secretion system]), PTX can interact with almost all mammalian cells, which explains the variety of biological activities of the toxin. <br /> | ||
No specific receptors for PTX have been identified but many cell surface [http://en.wikipedia.org/wiki/Sialoglycoprotein '''sialoglycoproteins'''] are involved in the binding of PTX | No specific receptors for PTX have been identified but many cell surface [http://en.wikipedia.org/wiki/Sialoglycoprotein '''sialoglycoproteins'''] are involved in the binding of PTX | ||
<ref name="Peppler (1988)"> | <ref name="Peppler (1988)"> | ||
PMID:2454226 | |||
</ref> | </ref> | ||
, together with '''glycoproteins''': sugar moieties allow the recognition of the toxin and the carbohydrate sequence '''NeuAcα(2,6)-Galβ4GlcNAc''' is particularly important | , together with '''glycoproteins''': sugar moieties allow the recognition of the toxin and the carbohydrate sequence '''NeuAcα(2,6)-Galβ4GlcNAc''' is particularly important however sugar sequence alone is not sufficient | ||
<ref name="Peppler (1988)"> | <ref name="Peppler (1988)"> | ||
PMID:3350815 | |||
</ref> | </ref>. | ||
<br /> | <br /> | ||
PTX binds its target cells through the ''B oligomer'' : ''S2'' and ''S3'' subunits contains at least two '''carbohydrate-binding sites''' | PTX binds its target cells through the ''B oligomer'' : ''S2'' and ''S3'' subunits contains at least two '''carbohydrate-binding sites''' | ||
<ref name="Read (1994)"> | <ref name="Read (1994)"> | ||
PMID:7634099 | |||
</ref> | </ref> | ||
. The N-terminal regions of these subunits are involved in receptor binding and the C-terminal domains of S2 and S3 adopt a fold found in other carbohydrate-binding proteins [73]. <br /> | . The N-terminal regions of these subunits are involved in receptor binding and the C-terminal domains of S2 and S3 adopt a fold found in other carbohydrate-binding proteins [73]. <br /> | ||
The B oligomer of PTX is involved in some biological activities of the toxin, independently of the enzyme activity. Thus '' | The B oligomer of PTX is involved in some biological activities of the toxin, independently of the enzyme activity. Thus <scene name='56/568016/Ptx_asn105/1'>Asn105</scene> in ''S2'' and <scene name='56/568016/Ptx_lys105/1'>Lys105</scene> in ''S3'' are important for the mitogenic activity of pertussis toxin on murine T lymphocytes | ||
<ref name="Locht93"> | <ref name="Locht93"> | ||
PMID:8418210 | |||
</ref> | </ref> | ||
, but not on human T cells | , but not on human T cells | ||
<ref name="Klein93"> | <ref name="Klein93"> | ||
PMID:8500874 | |||
</ref>. | </ref>. | ||
==Toxin entry and trafficking in target cells== | ==Toxin entry and trafficking in target cells== | ||
After binding to the target cell receptors, PTX enters the cells via receptor mediated endocytosis, and then follows the ''retrograde transport system'', involving both the Golgi apparatus and the endoplasmic reticulum | |||
After binding to the target cell receptors, PTX enters the cells via receptor mediated endocytosis, and then follows the retrograde transport system, involving both the Golgi apparatus and the endoplasmic reticulum | |||
<ref name="Schmidt MA (1997)"> | <ref name="Schmidt MA (1997)"> | ||
PMID:9174670 | |||
</ref> | </ref> | ||
<ref name="Xu95"> | <ref name="Xu95"> | ||
PMID:7868253 | |||
</ref>. | </ref>. | ||
Electron microscopy studies have shown that PTX enters the cells via ''coated pits'' | |||
Electron microscopy studies have shown that PTX enters the cells via coated pits | |||
<ref name="Schmidt MA (1997)"> | <ref name="Schmidt MA (1997)"> | ||
PMID:9174670 | |||
</ref>. | </ref>. | ||
But for now, PTX does not contain a clearly identified translocation domain in the B moiety. | But for now, PTX does not contain a clearly identified translocation domain in the B moiety. | ||
Line 56: | Line 55: | ||
S1 is able to bind to phospholipids bilayers | S1 is able to bind to phospholipids bilayers | ||
<ref name="Carbonetti08"> | <ref name="Carbonetti08"> | ||
PMID:9174670 | |||
</ref> | </ref> | ||
, suggesting that it may directly interact with the target cell membranes and mediate its translocation, and also that the B oligomer is not essential for this step. Results obtained from cell transfection experiments support this hypothesis | , suggesting that it may directly interact with the target cell membranes and mediate its translocation, and also that the B oligomer is not essential for this step. Results obtained from cell transfection experiments support this hypothesis | ||
<ref name="Carbonetti01"> | <ref name="Carbonetti01"> | ||
PMID:11207619 | |||
</ref> | </ref> | ||
<ref name="Locht00"> | <ref name="Locht00"> | ||
PMID:11111919 | |||
</ref>. | </ref>. | ||
Binding of ATP to PTX | Binding of ATP to PTX | ||
<ref name="Read96"> | <ref name="Read96"> | ||
PMID:8637000 | |||
</ref> | </ref> | ||
destabilizes the S1–B oligomer interactions and results in the release of S1 from the holotoxin | destabilizes the S1–B oligomer interactions and results in the release of S1 from the holotoxin | ||
<ref name="Read97"> | <ref name="Read97"> | ||
PMID:9333321 | |||
</ref>. | </ref>. | ||
This was proposed to occur in the endoplasmic reticulum, as it | This was proposed to occur in the endoplasmic reticulum, as it contains ATP and [http://en.wikipedia.org/wiki/Protein_disulfide-isomerase disulfide isomerases], that may reduce the intramolecular disulphide bonds of S1, therefore help to release the subunit from the holotoxin | ||
<ref name="Hewlett83"> | <ref name="Hewlett83"> | ||
PMID:6311827 | |||
</ref>. | </ref>. | ||
These observations imply that the holotoxin traffics via the endosomal pathway and Golgi apparatus to the endoplasmic reticulum, where it meet ATP and disulphide isomerase, leading to the release of the S1 subunit. S1 then translocate directly through the endoplasmic reticulum membrane into the cytosol | These observations imply that the holotoxin traffics via the endosomal pathway and Golgi apparatus to the endoplasmic reticulum, where it meet ATP and disulphide isomerase, leading to the release of the S1 subunit. S1 then translocate directly through the endoplasmic reticulum membrane into the cytosol. | ||
<applet load="1bcp" size="300" color="white" frame="true" align="right" caption="PTX bound to ATP : [[1bcp]]" scene=56/568016/Ptx_atp/2 /> | |||
==Mechanism of pertussis toxin== | ==Mechanism of pertussis toxin== | ||
Pertussis toxin acts on target cells through its A protomer which contains the '''enzymatically active S1 subunit'''. <br /> | Pertussis toxin acts on target cells through its A protomer which contains the '''enzymatically active S1 subunit'''. <br /> | ||
This subunit catalyzes [http://en.wikipedia.org/wiki/ADP_ribosylation '''ADP-ribosylation'''] of the ''α-subunit of trimeric G proteins'', which disturbs functions of the target cells and therefore | This subunit catalyzes [http://en.wikipedia.org/wiki/ADP_ribosylation '''ADP-ribosylation'''] of the ''α-subunit of trimeric G proteins'', which disturbs functions of the target cells and therefore leads to various biological effects. | ||
In facts, substrates of PTX are regulators of the membrane-bound [http://en.wikipedia.org/wiki/Adenylate_cyclase adenylate cyclase] | In facts, substrates of PTX are regulators of the membrane-bound [http://en.wikipedia.org/wiki/Adenylate_cyclase adenylate cyclase]. When ADP-ribosylation by PTX occurs, ''the downregulation of the adenylate cyclase activity is inhibited''. This inhibition leads to increase [http://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate cAMP] levels in cells, which explains the amount of biological activities of the toxin. | ||
The ADP-ribosylation of trimeric G proteins occurs on a '''cysteine residue''' in the ''C-terminal part of the α-subunit'' | The ADP-ribosylation of trimeric G proteins occurs on a '''cysteine residue''' in the ''C-terminal part of the α-subunit'' | ||
<ref name="Moss85"> | <ref name="Moss85"> | ||
PMID:3934172 | |||
</ref>. <br /> | </ref>. <br /> | ||
For that, the donor substrate used by PTX is '''NAD<sup>+</sup>''', which binds the toxin through '' | For that, the donor substrate used by PTX is '''NAD<sup>+</sup>''', which binds the toxin through <scene name='56/568016/Ptx_trp26/1'>Trp26</scene> | ||
<ref name="Barbieri89"> | <ref name="Barbieri89"> | ||
PMID:2551899 | |||
</ref> | </ref> | ||
<ref name="Feron89"> | <ref name="Feron89"> | ||
PMID:2470088 | |||
</ref> | </ref> | ||
, '' | , <scene name='56/568016/Ptx_arg9/1'>Arg9</scene> | ||
<ref name="Keith88"> | <ref name="Keith88"> | ||
PMID:2459776 | |||
</ref> | </ref> | ||
and '' | and <scene name='56/568016/Ptx_s1/2'>Cys41</scene> | ||
<ref name="Keith90"> | <ref name="Keith90"> | ||
PMID:2155232 | |||
</ref> | </ref> | ||
located in the ''active site of S1''. <br /> | located in the ''active site of S1''. <br /> | ||
Concerning the acceptor substrate, it binds to the toxin through '' | Concerning the acceptor substrate, it binds to the toxin through <scene name='56/568016/Ptx_180_219/1'>residues 180-219</scene> in the ''C-terminal region of S1'' | ||
<ref name="Barbieri91"> | <ref name="Barbieri91"> | ||
PMID:1748655 | |||
</ref>. | </ref>. | ||
These residues show indeed a high affinity for the G protein and are involved in the catalysis of the ADP-ribosylation | These residues show indeed a high affinity for the G protein and are involved in the catalysis of the ADP-ribosylation | ||
<ref name="Barbieri94"> | <ref name="Barbieri94"> | ||
PMID:8144593 | |||
</ref>. <br /> | </ref>. <br /> | ||
In the S1 subunit, the ''catalytic residues'' '' | In the S1 subunit, the ''catalytic residues'' <scene name='56/568016/Ptx_his35/1'>His35</scene> | ||
<ref name="Locht94"> | <ref name="Locht94"> | ||
PMID:8119996 | |||
</ref> | </ref> | ||
<ref name="Barbieri94"> | <ref name="Barbieri94"> | ||
PMID:8144593 | |||
</ref> | </ref> | ||
and '' | and <scene name='56/568016/Ptx_glu129/1'>Glu129</scene> | ||
<ref name="Locht93"> | <ref name="Locht93"> | ||
PMID:7901213 | |||
</ref> | </ref> | ||
have been identified: His35 is involved in the ionization of the nucleophilic thiol of the cysteine residue in the G protein via its ε-N | have been identified: His35 is involved in the ionization of the nucleophilic thiol of the cysteine residue in the G protein via its ε-N <ref name="Transit">PMID:9204866</ref>and the carboxylate group of the <scene name='56/568016/Ptx_glu129/1'>Glu129</scene> side chain is in contact with the 2'-ribo-hydroxyl of the NAD<sup>+</sup> | ||
<ref name="Antoine95"> | <ref name="Antoine95"> | ||
PMID:8527486 | |||
</ref>. | </ref>. | ||
Line 136: | Line 137: | ||
cAMP is primary in many biological processes that's why its accumulation leads to the disruption of cellular metabolism and pathological events, according to infected cells. <br /> | cAMP is primary in many biological processes that's why its accumulation leads to the disruption of cellular metabolism and pathological events, according to infected cells. <br /> | ||
Thus biological activities of PTX are especially ''histamine sensitization'', ''islet activation'' and ''lymphocytosis''. | Thus biological activities of PTX are especially ''histamine sensitization'', ''islet activation'' and ''lymphocytosis''. | ||
==Structural informations allow to produce efficient vaccine== | |||
Crystal structure provided insight into the pathogenic mechanisms of PTX. Informations about the tertiary structure of the active site is a good basis for elimination of the catalytic activity in recombinant molecules for vaccine use. | |||
For example, one highly detoxified PTX analog contains two alterations in the S1 subunit (Arg9 to Lys; Glu129 to Gly), each of which is able to totally abolish the enzymativ activity of the toxin. This molecule already belongs to the new-generation of pertussis vaccines <ref name="Karzon90">PMID:2190139</ref>. | |||
==See Also== | ==See Also== | ||
Line 141: | Line 147: | ||
==Reference== | ==Reference== | ||
<references/> | |||
==Proteopedia Page Contributors and Editors== | |||
[[User:Lea Clusan|Lea Clusan]] and [[User:Paul Giroud|Paul Giroud]] |